Matches in SemOpenAlex for { <https://semopenalex.org/work/W2156648140> ?p ?o ?g. }
- W2156648140 endingPage "697" @default.
- W2156648140 startingPage "692" @default.
- W2156648140 abstract "In this prospective study, we determined the frequency of opioid-related chemical coping among advanced cancer patients, as diagnosed by palliative medicine specialists. We also determined predictors for chemical coping and the concordance between the physician's diagnosis and documentation in the medical records.Palliative medicine specialists evaluated and diagnosed consecutive patients seen for chemical coping. The proportion of patients identified as chemically coping was compared with the proportion documented in the medical records. Demographic data; cancer diagnosis; history of smoking; substance abuse; psychiatric disease; morphine equivalent daily dosage; Cut-down, Annoyed, Guilty, and Eye-opener (CAGE) questionnaire scores; and Edmonton Symptom Assessment System scores were also collected.A total of 432 patients were evaluated. Overall, 76 patients (18%; 95% confidence interval [CI]: 14%-21%) were diagnosed as chemically coping. Documentation of chemical coping in the medical records was reported for only 15 patients (4%; 95% CI: 2%-6%). CAGE positivity (odds ratio [OR]: 2.89), younger age (OR: 0.97 per year), better performance status (OR: 0.68 per point), pain (OR: 1.20 per point), and well-being (OR: 1.28 per point) were found to be significant predictors of chemical coping by protocol definition. After recursive partitioning, 21 of 50 patients (42%) who were CAGE positive and had an Eastern Cooperative Oncology Group performance status ≤2 were diagnosed as chemically coping.Approximately 18% of palliative care patients seen were diagnosed as chemically coping by palliative medicine specialists. The frequency of documentation in the medical records was significantly lower. Better and safer ways for physicians to assess and report chemical coping are needed.Cancer pain is a multidimensional symptom for which opioids are the mainstay of treatment. However, opioids can have a double effect resulting in drug-seeking behaviors. Chemical coping occurs when a patient uses opioids in a nonprescribed way to cope with various stressful events. This can lead to misuse of opioids and complications including neurotoxicities, respiratory depression, and death. Proper diagnosis and documentation is needed to ensure proper management of pain and to avoid unnecessary harm. The findings of this study suggest that ∼18% of advanced cancer patients seen by a palliative care service were diagnosed as chemical coping, but only 4% were documented in the medical records." @default.
- W2156648140 created "2016-06-24" @default.
- W2156648140 creator A5005610042 @default.
- W2156648140 creator A5013672944 @default.
- W2156648140 creator A5033579945 @default.
- W2156648140 creator A5034577396 @default.
- W2156648140 creator A5041306543 @default.
- W2156648140 creator A5041556537 @default.
- W2156648140 creator A5047699558 @default.
- W2156648140 creator A5058392144 @default.
- W2156648140 creator A5059712158 @default.
- W2156648140 creator A5075931431 @default.
- W2156648140 date "2015-05-01" @default.
- W2156648140 modified "2023-10-05" @default.
- W2156648140 title "Frequency, Predictors, and Medical Record Documentation of Chemical Coping Among Advanced Cancer Patients" @default.
- W2156648140 cites W1966738036 @default.
- W2156648140 cites W1978448995 @default.
- W2156648140 cites W1986364137 @default.
- W2156648140 cites W1988009262 @default.
- W2156648140 cites W1991207541 @default.
- W2156648140 cites W1993666488 @default.
- W2156648140 cites W1997268860 @default.
- W2156648140 cites W2029514719 @default.
- W2156648140 cites W2031845958 @default.
- W2156648140 cites W2035009266 @default.
- W2156648140 cites W2036154210 @default.
- W2156648140 cites W2037921495 @default.
- W2156648140 cites W2040332648 @default.
- W2156648140 cites W2041342242 @default.
- W2156648140 cites W2047781148 @default.
- W2156648140 cites W2050604065 @default.
- W2156648140 cites W2054897163 @default.
- W2156648140 cites W2055376632 @default.
- W2156648140 cites W2059471641 @default.
- W2156648140 cites W2065621119 @default.
- W2156648140 cites W2067975730 @default.
- W2156648140 cites W2089819029 @default.
- W2156648140 cites W2096164040 @default.
- W2156648140 cites W2103909679 @default.
- W2156648140 cites W2104969504 @default.
- W2156648140 cites W2108444101 @default.
- W2156648140 cites W2119520080 @default.
- W2156648140 cites W2121571319 @default.
- W2156648140 cites W2131664262 @default.
- W2156648140 cites W2151163352 @default.
- W2156648140 cites W2161937939 @default.
- W2156648140 cites W2164682608 @default.
- W2156648140 cites W2327765759 @default.
- W2156648140 cites W2342007011 @default.
- W2156648140 cites W2406701612 @default.
- W2156648140 cites W4254121089 @default.
- W2156648140 doi "https://doi.org/10.1634/theoncologist.2015-0012" @default.
- W2156648140 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4571788" @default.
- W2156648140 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25933929" @default.
- W2156648140 hasPublicationYear "2015" @default.
- W2156648140 type Work @default.
- W2156648140 sameAs 2156648140 @default.
- W2156648140 citedByCount "75" @default.
- W2156648140 countsByYear W21566481402016 @default.
- W2156648140 countsByYear W21566481402017 @default.
- W2156648140 countsByYear W21566481402018 @default.
- W2156648140 countsByYear W21566481402019 @default.
- W2156648140 countsByYear W21566481402020 @default.
- W2156648140 countsByYear W21566481402021 @default.
- W2156648140 countsByYear W21566481402022 @default.
- W2156648140 countsByYear W21566481402023 @default.
- W2156648140 crossrefType "journal-article" @default.
- W2156648140 hasAuthorship W2156648140A5005610042 @default.
- W2156648140 hasAuthorship W2156648140A5013672944 @default.
- W2156648140 hasAuthorship W2156648140A5033579945 @default.
- W2156648140 hasAuthorship W2156648140A5034577396 @default.
- W2156648140 hasAuthorship W2156648140A5041306543 @default.
- W2156648140 hasAuthorship W2156648140A5041556537 @default.
- W2156648140 hasAuthorship W2156648140A5047699558 @default.
- W2156648140 hasAuthorship W2156648140A5058392144 @default.
- W2156648140 hasAuthorship W2156648140A5059712158 @default.
- W2156648140 hasAuthorship W2156648140A5075931431 @default.
- W2156648140 hasBestOaLocation W21566481401 @default.
- W2156648140 hasConcept C118552586 @default.
- W2156648140 hasConcept C126322002 @default.
- W2156648140 hasConcept C156957248 @default.
- W2156648140 hasConcept C159110408 @default.
- W2156648140 hasConcept C160798450 @default.
- W2156648140 hasConcept C195910791 @default.
- W2156648140 hasConcept C2994186709 @default.
- W2156648140 hasConcept C44249647 @default.
- W2156648140 hasConcept C71924100 @default.
- W2156648140 hasConcept C73282008 @default.
- W2156648140 hasConceptScore W2156648140C118552586 @default.
- W2156648140 hasConceptScore W2156648140C126322002 @default.
- W2156648140 hasConceptScore W2156648140C156957248 @default.
- W2156648140 hasConceptScore W2156648140C159110408 @default.
- W2156648140 hasConceptScore W2156648140C160798450 @default.
- W2156648140 hasConceptScore W2156648140C195910791 @default.
- W2156648140 hasConceptScore W2156648140C2994186709 @default.
- W2156648140 hasConceptScore W2156648140C44249647 @default.
- W2156648140 hasConceptScore W2156648140C71924100 @default.
- W2156648140 hasConceptScore W2156648140C73282008 @default.